Back

Risk of adverse cardiac events in patients undergoing surgery after coronary drug-eluting stent implantation for acute coronary syndrome and stable angina pectoris.

27 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters 3 - Best Posters in stable CAD CAD and comorbidities ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Gro Egholm

Odense University Hospital, Odense (Denmark)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor R. Twerenbold (Hamburg, DE)
Abstract
Presentation thumbnail
Doctor T. Zanchin (London, GB)
Abstract Slides
Presentation thumbnail
Doctor S. Farhan (New York, US)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 3 - Best Posters in stable CAD

The Event

Event poster

ESC Congress 2017

27 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Perioperative risk and benefit of antiplatelet therapy in patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention with second-generation drug-eluting stents.
27 August 2022
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022
thumbnail
Congress Presentation
Ten-year major clinical outcomes between first- and second-generation Drug-Eluting Stents in unstable angina patients underwent Percutaneous Coronary Intervention
28 August 2023
thumbnail
Congress Presentation
Percutaneous coronary intervention with everolimus-eluting stents versus coronary artery bypass surgery in patients with stable angina and an isolated proximal left anterior descending artery disease
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources